humanitarian Archived signal RAW fallback · translation pending

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reported by EMA What Is New Oct 19, 2026 · 11:02 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 41, Status: Authorised11:02 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 41, Status: Authorised11:02 UTC EMA What Is NewMedicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Eiyzey, Aflibercept, Fecha de autorización: 14/08/2025, Revisión: 1, Estado: Autorizado10:26 UTC EMA What Is NewMedicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Eiyzey, Aflibercept, Fecha de autorización: 14/08/2025, Revisión: 1, Estado: Autorizado10:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Afiveg, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: Authorised10:25 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Afiveg, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: Authorised10:25 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 5, Status: Authorised10:24 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 5, Status: Authorised10:24 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 6, Status: Authorised09:55 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 6, Status: Authorised09:55 UTC EMA What Is NewMedicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Ahzantive, Aflibercept, Fecha de autorización: 13/01/2025, Revisión: 6, Estado: Autorizado08:16 UTC EMA What Is NewMedicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Ahzantive, Aflibercept, Fecha de autorización: 13/01/2025, Revisión: 6, Estado: Autorizado08:16 UTC

INCIDENT EVOLUTION

1 recorded state

Oct 19 · 11:33 UTC

Signal first indexedP2 · 99% quality · 2 sources

Explore this day in the archive →